Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    Open Studies | "Pemphigoid, Bullous"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
Condition: Pemphigoid, Bullous
Interventions: Drug: Mepolizumab (a-IL-5 antibody);   Drug: Placebo
2 Recruiting Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid
Condition: Pemphigoid, Bullous
Intervention: Biological: Bertilimumab
3 Recruiting Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
Condition: Bullous Pemphigoid
Interventions: Drug: treatment with topical superpotent corticosteroid therapy;   Drug: treatment with systemic therapy (methotrexate);   Drug: treatment systemic therapy (prednisone);   Drug: treatment with systemic therapy (prednisone);   Drug: treatment with systemic therapy (doxycycline)
4 Recruiting Pruritus and Pemphigoid in Nursing Home Patients
Conditions: Pemphigoid;   Pruritus
Intervention: Other: Blood sample
5 Recruiting Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid
Condition: Bullous Pemphigoid
Intervention: Other: Blood sample and cotton skin swabs
6 Recruiting Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid
Condition: Bullous Pemphigoid
Interventions: Procedure: Impedance analysis;   Drug: Clobetasol Propionate cream treatment
7 Recruiting Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid
Conditions: Pemphigoid, Bullous;   Pemphigus;   Lupus Erythematosus, Cutaneous
Intervention:
8 Recruiting Autoimmune Blistering Diseases Study
Conditions: Pemphigus Vulgaris;   Pemphigus Foliaceus;   Bullous Pemphigoid
Intervention: Other: Questionnaires
9 Available Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Conditions: Limbal Stem Cell Deficiency;   Stevens-johnson Syndrome;   Ocular Cicatricial Pemphigoid;   Chemical Burn
Intervention: Biological: cultivated oral mucosal epithelial sheet transplantation
10 Recruiting Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Conditions: Bullous Pemphigoid (BP);   Cold Agglutinin Disease;   Warm Autoimmune Hemolytic Anemia;   End-stage Renal Disease (ESRD)
Interventions: Drug: TNT009;   Other: Placebo
11 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin

Study has passed its completion date and status has not been verified in more than two years.